Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation.
暂无分享,去创建一个
N. Hay | A. Wagner | E. Uhlmann | G. Chinnadurai | T. Subramanian | E. Uhlmann | C. D'Sa-Eipper | C. D’Sa-Eipper | Erik J. Uhlmann
[1] G. Chinnadurai,et al. Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. , 1996, Oncogene.
[2] J. M. Boyd,et al. Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins. , 1995, Oncogene.
[3] J. M. Boyd,et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. , 1995, Oncogene.
[4] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] G. Evan,et al. Induction of apoptosis by the Bcl-2 homologue Bak , 1995, Nature.
[6] N. Hay,et al. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.
[7] D. Vaux,et al. Analysis of the Role of bcl‐2 in Apoptosis , 1994, Immunological reviews.
[8] John Calvin Reed,et al. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] S. Krajewski,et al. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. , 1994, Oncogene.
[10] S. Krajewski,et al. Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoprotein. , 1994, DNA and cell biology.
[11] M. Clarke,et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] John Calvin Reed,et al. Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.
[13] G. Chinnadurai,et al. Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. , 1994, Virology.
[14] M. Oren. Relationship of p53 to the control of apoptotic cell death. , 1994, Seminars in cancer biology.
[15] John Calvin Reed,et al. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. , 1994, Oncogene.
[16] E. White,et al. Bcl-2 blocks p53-dependent apoptosis , 1994, Molecular and cellular biology.
[17] H. Katz. bcl-2 protein in non-small-cell lung carcinoma. , 1994, The New England journal of medicine.
[18] John Calvin Reed. Bcl-2 and the regulation of programmed cell death , 1994, The Journal of cell biology.
[19] M. Rowe,et al. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. Korsmeyer,et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death , 1993, Cell.
[21] N. Hay,et al. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 , 1993, Molecular and cellular biology.
[22] E. White,et al. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.
[23] G. Elia,et al. Bcl‐2 proto‐oncogene expression in epstein‐barr‐virus‐associated nasopharyngeal carcinoma , 1993, International journal of cancer.
[24] M. Campbell,et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. , 1992, Cancer research.
[25] G. Evan,et al. Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.
[26] D. Green,et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.
[27] S. Korsmeyer. Bcl-2 initiates a new category of oncogenes: regulators of cell death. , 1992, Blood.
[28] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[29] S. Fields,et al. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.
[31] Gwyn T. Williams. Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.
[32] O. Halevy,et al. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 , 1990, Cell.
[33] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[34] S. Korsmeyer,et al. Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.
[35] P. Earl,et al. Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes , 1987, Molecular and cellular biology.
[36] J. Sklar,et al. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.
[37] S. Korsmeyer,et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.
[38] Y. Tsujimoto,et al. Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.
[39] J. M. Boyd,et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. , 1994, Cell.